These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34728330)

  • 1. A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products.
    Reynolds G; Reynolds J; Gilmour N; Cubberley R; Spriggs S; Aptula A; Przybylak K; Windebank S; Maxwell G; Baltazar MT
    Regul Toxicol Pharmacol; 2021 Dec; 127():105075. PubMed ID: 34728330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation risk assessment for skin allergy: Decision making using new approach methodologies.
    Gilmour N; Reynolds J; Przybylak K; Aleksic M; Aptula N; Baltazar MT; Cubberley R; Rajagopal R; Reynolds G; Spriggs S; Thorpe C; Windebank S; Maxwell G
    Regul Toxicol Pharmacol; 2022 Jun; 131():105159. PubMed ID: 35311660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products.
    Baltazar MT; Cable S; Carmichael PL; Cubberley R; Cull T; Delagrange M; Dent MP; Hatherell S; Houghton J; Kukic P; Li H; Lee MY; Malcomber S; Middleton AM; Moxon TE; Nathanail AV; Nicol B; Pendlington R; Reynolds G; Reynolds J; White A; Westmoreland C
    Toxicol Sci; 2020 Jul; 176(1):236-252. PubMed ID: 32275751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information.
    Gilmour N; Alépée N; Hoffmann S; Kern PS; Van Vliet E; Bury D; Miyazawa M; Nishida H; Cosmetics Europe
    ALTEX; 2023; 40(3):439-451. PubMed ID: 36919358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision making in next generation risk assessment for skin allergy: Using historical clinical experience to benchmark risk.
    Reynolds J; Gilmour N; Baltazar MT; Reynolds G; Windebank S; Maxwell G
    Regul Toxicol Pharmacol; 2022 Oct; 134():105219. PubMed ID: 35835397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation risk assessment for skin sensitisation: A case study with propyl paraben.
    Assaf Vandecasteele H; Gautier F; Tourneix F; Vliet EV; Bury D; Alépée N
    Regul Toxicol Pharmacol; 2021 Jul; 123():104936. PubMed ID: 33905779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin sensitisation prediction using read-across, an illustrative next generation risk assessment (NGRA) case study for vanillin.
    Gautier F; Assaf Vandecasteele H; Tourneix F; van Vliet E; Alépée N; Bury D
    Regul Toxicol Pharmacol; 2023 Sep; 143():105458. PubMed ID: 37453556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products.
    Moxon TE; Li H; Lee MY; Piechota P; Nicol B; Pickles J; Pendlington R; Sorrell I; Baltazar MT
    Toxicol In Vitro; 2020 Mar; 63():104746. PubMed ID: 31837441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA data.
    Hoffmann S; Alépée N; Gilmour N; Kern PS; van Vliet E; Boislève F; Bury D; Cloudet E; Klaric M; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Tam Brami MT; Varçin M; Api AM; Europe C
    Regul Toxicol Pharmacol; 2022 Jun; 131():105169. PubMed ID: 35447229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Read-across can increase confidence in the Next Generation Risk Assessment for skin sensitisation: A case study with resorcinol.
    Gautier F; Tourneix F; Assaf Vandecasteele H; van Vliet E; Bury D; Alépée N
    Regul Toxicol Pharmacol; 2020 Nov; 117():104755. PubMed ID: 32800849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
    Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
    Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation risk assessment for occupational chemical safety - A real world example with sodium-2-hydroxyethane sulfonate.
    Wood A; Breffa C; Chaine C; Cubberley R; Dent M; Eichhorn J; Fayyaz S; Grimm FA; Houghton J; Kiwamoto R; Kukic P; Lee M; Malcomber S; Martin S; Nicol B; Reynolds J; Riley G; Scott S; Smith C; Westmoreland C; Wieland W; Williams M; Wolton K; Zellmann T; Gutsell S
    Toxicology; 2024 Aug; 506():153835. PubMed ID: 38857863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients.
    Dent MP; Vaillancourt E; Thomas RS; Carmichael PL; Ouedraogo G; Kojima H; Barroso J; Ansell J; Barton-Maclaren TS; Bennekou SH; Boekelheide K; Ezendam J; Field J; Fitzpatrick S; Hatao M; Kreiling R; Lorencini M; Mahony C; Montemayor B; Mazaro-Costa R; Oliveira J; Rogiers V; Smegal D; Taalman R; Tokura Y; Verma R; Willett C; Yang C
    Regul Toxicol Pharmacol; 2021 Oct; 125():105026. PubMed ID: 34389358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment.
    Alexander-White C; Bury D; Cronin M; Dent M; Hack E; Hewitt NJ; Kenna G; Naciff J; Ouedraogo G; Schepky A; Mahony C; Europe C
    Regul Toxicol Pharmacol; 2022 Mar; 129():105094. PubMed ID: 34990780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Read-across and new approach methodologies applied in a 10-step framework for cosmetics safety assessment - A case study with parabens.
    Ouedraogo G; Alexander-White C; Bury D; Clewell HJ; Cronin M; Cull T; Dent M; Desprez B; Detroyer A; Ellison C; Giammanco S; Hack E; Hewitt NJ; Kenna G; Klaric M; Kreiling R; Lester C; Mahony C; Mombelli E; Naciff J; O'Brien J; Schepky A; Tozer S; van der Burg B; van Vugt-Lussenburg B; Stuard S; Cosmetics Europe
    Regul Toxicol Pharmacol; 2022 Jul; 132():105161. PubMed ID: 35508214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin sensitisation testing in practice: Applying a stacking meta model to cosmetic ingredients.
    Tourneix F; Alépée N; Detroyer A; Eilstein J; Ez-Zoubir M; Teissier SM; Noçairi H; Piroird C; Basketter D; Del Bufalo A
    Toxicol In Vitro; 2020 Aug; 66():104831. PubMed ID: 32198056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation risk assessment: an
    Ebmeyer J; Najjar A; Lange D; Boettcher M; Voß S; Brandmair K; Meinhardt J; Kuehnl J; Hewitt NJ; Krueger CT; Schepky A
    Front Pharmacol; 2024; 15():1345992. PubMed ID: 38515841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New framework for a non-animal approach adequately assures the safety of cosmetic ingredients - A case study on caffeine.
    Bury D; Alexander-White C; Clewell HJ; Cronin M; Desprez B; Detroyer A; Efremenko A; Firman J; Hack E; Hewitt NJ; Kenna G; Klaric M; Lester C; Mahony C; Ouedraogo G; Paini A; Schepky A;
    Regul Toxicol Pharmacol; 2021 Jul; 123():104931. PubMed ID: 33905778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
    Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.